NCTY

The9 Ltd ADR
NASDAQFINANCIAL SERVICESCAPITAL MARKETS

Key Statistics

Market Cap
$70.72M
P/E Ratio
EPS
$-4.03
Beta
2.09
52W High
$11.60
52W Low
$3.14
50-Day MA
$4.56
200-Day MA
$5.87
Dividend Yield
Profit Margin
-214.20%
Forward P/E
PEG Ratio
0.00

About The9 Ltd ADR

The9 Limited, is an Internet company in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Official WebsiteChinaFY End: December

Fundamentals

Revenue (TTM)$83.78M
Gross Profit (TTM)$2.42M
EBITDA$-298.50M
Operating Margin-774.00%
Return on Equity-56.70%
Return on Assets-27.80%
Revenue/Share (TTM)$9.52
Book Value$3.53
Price-to-Book1.08
Price-to-Sales (TTM)0.84
EV/Revenue7.85
EV/EBITDA50.07
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-65.30%
Shares Outstanding$15.27M
Float$4.70M
% Insiders17.39%
% Institutions0.45%

Historical Volatility

HV 10-Day
88.16%
HV 20-Day
156.46%
HV 30-Day
134.68%
HV 60-Day
106.67%
HV Rank
99.6%

Volatility is currently contracting

Latest News

The9 Limited to Report Second Quarter 2026 Results on August 24, 2026

SHANGHAI, Aug. 17, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today announced that it will report its unaudited consolidated results for the second quarter ended June 30, 2026, before the U.S. market opens on Monday, August 24, 2026. The Company will host a conference call on Monday, August 24, 2026 at 8:30 PM Hong Kong Time (8:30 AM U.S. Eastern Time) to discuss the results.

PRNewsWire8/17/2026Neutral
The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination

NYB Obtained Notice of Effectiveness from SEC for Its Form F-4 Registration Statement The9 expects to own 15% to 16% of the combined company following NYB listing HONG KONG, Aug. 11, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today announced that its Singapore investee Nanyang Biologics Pte. Ltd. ("NYB") obtained the notice of effectiveness from the U.S. Securities and Exchange Commission for its Form F-4 registration statement filed in connection with the previously announced business combination, a key milestone toward NYB's planned listing on Nasdaq under the reserved ticker symbol "NYB.

PRNewsWire8/11/2026Neutral
The9 Expands Brand Partnership Network Across Southeast Asia

the9bit Signs 41 Brand Partners Across Indonesia, Malaysia, and Vietnam, with 127 More in the Pipeline SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today announced continued progress in the Southeast Asia offline-to-online ("O2O") initiative of the9bit, its AI-powered digital asset ecosystem. The initiative has built a growing network of brand partnerships across Indonesia, Malaysia, and Vietnam as part of a strategy of integrating digital entertainment experiences with physical retail environments.

PRNewsWire8/6/2026Neutral
The9 Posts Record Quarterly Profit; Expects Sequential Growth Through 2026

Digital asset gains power record quarter; AI-powered game creation platform the9bit surpasses 8 million registered users SHANGHAI, July 27, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today reported net income of US$23 million for the three months ended March 31, 2026, delivering the strongest quarter in the Company's history since its 2004 IPO. The result reflects substantial digital asset-related income, accelerating adoption of the9bit, and the continued build-out of the Company's cryptocurrency operations and digital asset holdings.

PRNewsWire7/27/2026Neutral
The9 Names George Lai Chief Executive Officer

Leadership transition reinforces management's long-term alignment with shareholders SHANGHAI, July 27, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today announced the appointment of George Lai as Chief Executive Officer ("CEO"), effective July 27, 2026. Mr. Lai succeeds Founder and Chairman Jun Zhu, who will continue to serve as Executive Chairman of the Board.

PRNewsWire7/27/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NCTY and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 8/18/2026